Locally Delivered 1% Metformin Gel in Peri-implantitis

• Status: Completed
• Trial end date: 2017-07-24
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the efficacy of 1% local metformin gel in deep periimplant pockets of type 2 diabetes mellitus patients. Half of the participants will receive 1% metformin gel with manual debridement while the other half will receive a placebo with manual debridement.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: King Saud University
• Treatments: Metformin

Criteria

Inclusion Criteria:

• Type 2 diabetes mellitus patients.

• Patients with peri-implantitis

Exclusion Criteria:

• History of any other systemic diseases

• Cigarette smokers

• Smokeless tobacco users

• Patients who underwent scaling in the last 1 year

• Patients who took antibiotics in tje past 6 months